China VC-backed Harbour BioMed acquires Harbour Antibodies

China VC-backed Harbour BioMed acquires Harbour Antibodies

Visual from Harbour Antibodies website

Shanghai-based Harbour BioMed has acquired US-based Harbour Antibodies BV for cash and an equity interest in Harbour BioMed to create a new, global oncology-focused biotechnology company.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter